Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary. [electronic resource]
Producer: 19821012Description: 1675-6 p. digitalISSN:- 0361-5960
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Drug Evaluation
- Female
- Germanium -- adverse effects
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Organometallic Compounds
- Ovarian Neoplasms -- drug therapy
- Spiro Compounds -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.